{
  "Q0": "Whole exome sequencing (WES)",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.2": "ACMG",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "Yes",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81415",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "According to the policy, the following steps should be followed for claim submission: 1) Ensure the patient has been evaluated by a clinician with expertise in clinical genetics and genetic counseling was provided about potential risks; 2) Document that there is potential for a change in management and clinical outcome; 3) Document that previous genetic testing (chromosomal microarray) was non-diagnostic and there remains a strong clinical suspicion of genetic etiology; 4) Consider trio testing with biological parents or siblings when possible; 5) Use the appropriate CPT code (81415 for WES); 6) Include relevant ICD-10 diagnosis codes that match the patient's condition.",
  "match": true
}